Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2011;17(2):113-119. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.113

View: 8416 Download: 48 Crossref: 25

3

Evaluation of Predictive Value of Okuda, TNM, CLIP and JIS Staging Systems for Hepatocellular Carcinoma Patients

Sung-Wook Lee, M.D., Sang-Young Han, M.D., Kyoung-Tae Kim, M.D., Yang-Hyun Baek, M.D., In Young Koh, M.D., Byoung-Hee Kim, M.D., Eun-Hee Park, M.D., Jin-Seok Jang, M.D., Myung-Hwan Roh, M.D, Jong Cheol Choi, M.D.

Clin Mol Hepatol. 2007;13(2):196-207. Published online January 1, 1970

View: 2676 Download: 22

7

The Korean Journal of Evaluation of the Heptocellular Carcinoma Staging Systems

Soon Ho Um

Clin Mol Hepatol. 2006;12(2):251-256. Published online January 1, 1970

View: 2455 Download: 20

3

Modified CLIP Score as a New Prognostic Index for Patients with Hepatocellular Carcinoma

Seung Ho Han, M.D., Sang Young Han, M.D., Byoung Soung Go, M.D., Min Ji Kim, M.D., Jung Hyun Lee, M.D., Young Hun Koo, M.D., Seung Hoon Ryu, M.D., Jeong Hwan Cho, M.D., Jin Seok Jang, M.D., Jong Hoon Lee, M.D., Myung Hwan Roh, M.D., Seok Ryeol Choi, M.D., Joung Chel Choi, M.D. and Sung Wook Lee, M.D.

Clin Mol Hepatol. 2006;12(2):209-220. Published online January 1, 1970

View: 2714 Download: 24

Treatment Outcome and Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma (TNM Stage IVa) according to Anticancer drugs of Transhepatic Arterial Chemoinfusion

Sang Hoon Ahn, M.D., Kwang-Hyub Han, M.D., Young Hoon Youn, M.D.,Myoung Hwan Kim, M.D., Kun Hoon Song, M.D., Kwan Sik Lee, M. D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Do Yun Lee, M.D.* and Jong Tae Lee, M.D.*

Clin Mol Hepatol. 2000;6(4):456-467. Published online January 1, 2000

View: 2369 Download: 21

1 |

Viewed By 5300	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5245	MAFLD: How is it different from NAFLD?
Viewed By 5150	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3862	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3800	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search